Thailand Compulsory-Licensing Plan To Proceed Despite New Government
This article was originally published in PharmAsia News
Executive Summary
Although Thailand's military-appointed government is to be replaced soon by an elected government, plans to impose compulsory licensing on four cancer drugs are to proceed as planned. Public Health Minister Mongkol Na Songkhla said the decision was made on Jan. 4 and the pros and cons of the action had been thoroughly considered. Believed targeted for facing generic versions are letrozole and imatinib by Novartis, docetaxel by Sanofi-Aventis and erlotinib by Roche Holding. (Click here for more